A detailed history of Silvercrest Asset Management Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 147,953 shares of ABBV stock, worth $26.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
147,953
Previous 148,375 0.28%
Holding current value
$26.6 Million
Previous $25.4 Million 14.81%
% of portfolio
0.2%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $69,140 - $84,117
-422 Reduced 0.28%
147,953 $29.2 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $23 Million - $26.8 Million
-148,375 Reduced 50.0%
148,375 $25.4 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $22.3 Million - $26.1 Million
144,223 Added 94.56%
296,750 $50.9 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $3.1 Million - $3.53 Million
-19,399 Reduced 11.28%
152,527 $27.8 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $205,574 - $231,525
-1,494 Reduced 0.86%
171,926 $26.6 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $599,685 - $694,223
-4,489 Reduced 2.52%
173,420 $25.8 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $633,662 - $788,551
-4,782 Reduced 2.62%
177,909 $24 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $137,379 - $158,213
-950 Reduced 0.52%
182,691 $29.1 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $353,243 - $423,631
-2,554 Reduced 1.37%
183,641 $29.7 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $98,375 - $112,830
-733 Reduced 0.39%
186,195 $25 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $564,792 - $718,035
-4,104 Reduced 2.15%
186,928 $28.6 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $59,786 - $74,178
-453 Reduced 0.24%
191,032 $31 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $309,290 - $391,342
-2,879 Reduced 1.48%
191,485 $25.9 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $196,308 - $222,839
-1,845 Reduced 0.94%
194,364 $21 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $84,483 - $94,119
803 Added 0.41%
196,209 $22.1 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $288,179 - $317,250
-2,817 Reduced 1.42%
195,406 $21.1 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $275,678 - $372,194
-3,425 Reduced 1.7%
198,223 $21.2 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $593,724 - $696,836
-6,911 Reduced 3.31%
201,648 $17.7 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $847,643 - $1.13 Million
11,553 Added 5.86%
208,559 $20.5 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $311,148 - $471,738
4,824 Added 2.51%
197,006 $15 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $89,873 - $112,451
-1,246 Reduced 0.64%
192,182 $17 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $110,152 - $132,434
-1,749 Reduced 0.9%
193,428 $14.6 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $60,838 - $77,765
-926 Reduced 0.47%
195,177 $14.2 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $137,232 - $161,515
-1,779 Reduced 0.9%
196,103 $15.8 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $847,475 - $1.05 Million
-10,886 Reduced 5.21%
197,882 $18.2 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $120,561 - $134,027
-1,356 Reduced 0.65%
208,768 $19.7 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $259,733 - $307,323
-2,893 Reduced 1.36%
210,124 $19.5 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $201,961 - $270,445
-2,195 Reduced 1.02%
213,017 $20.2 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $380,271 - $416,999
-4,246 Reduced 1.93%
215,212 $20.8 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $15.3 Million - $19.6 Million
219,458
219,458 $19.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.